Leo Grünstein is the CEO and Founder of Spiden, a pioneering platform for real-time continuous biomarker and drug monitoring, aimed at advancing human well-being. He also serves as a Venture Builder, the Chairman and the originator of LG Capital, a Family Office dedicated to incubating innovative ventures. Leo Grünstein possesses extensive entrepreneurial experience, having co-founded over twenty international startups, securing numerous VC investments and achieving successful exits, such as the acquisition of MoneyPark for CHF 153 million in 2016. His background includes roles as a project manager at McKinsey & Co. and an analyst within HSBC's M&A team, complemented by an MBA from Columbia Business School and a B.A. from St. Gallen University.